Recombinant human CDK7 + Cyclin H + MNAT1 protein
Be the first to review this product! Submit a review
|
(2 Publications)
Recombinant human CDK7 + Cyclin H + MNAT1 protein is a Human Full Length protein, expressed in Baculovirus infected Sf9 cells, with >90%, suitable for SDS-PAGE, FuncS.
View Alternative Names
CAK, CAK1, CDKN7, MO15, STK1, CDK7, Cyclin-dependent kinase 7, 39 kDa protein kinase, CDK-activating kinase 1, Cell division protein kinase 7, Serine/threonine-protein kinase 1, TFIIH basal transcription factor complex kinase subunit, p39 Mo15, Cyclin-H, MO15-associated protein, p34, p37, CCNH, CAP35, MAT1, RNF66, MNAT1, CDK-activating kinase assembly factor MAT1, CDK7/cyclin-H assembly factor, Cyclin-G1-interacting protein, Menage a trois, RING finger protein 66, RING finger protein MAT1, p35, p36
- FuncS
Supplier Data
Functional Studies - Recombinant human CDK7 + Cyclin H + MNAT1 protein (AB64303)
The specific activity of CDK7 + Cyclin H + MNAT1 (ab64303) was determined to be 19nmol/min/mg as per activity assay protocol.
- FuncS
Unknown
Functional Studies - Recombinant human CDK7 + Cyclin H + MNAT1 protein (AB64303)
The specific activity of CDK7 + Cyclin H + MNAT1 (ab64303) was determined to be 20 nmol/min/mg as per activity assay protocol
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant human CDK7 + Cyclin H + MNAT1 protein (AB64303)
SDS PAGE analysis of ab64303
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant human CDK7 + Cyclin H + MNAT1 protein (AB64303)
SDS-PAGE analysis of ab64303. The purity of CDK7 + Cyclin H + MNAT1 (ab64303) was determined to be >90% by densitometry, CDK7 approx. MW 40kDa, CyclinH1 approx. MW 39kDa and MNAT1 approx. MW 37kDa
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Specifications
Form
Liquid
Additional notes
Affinity purified.
General info
Function
Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription (PubMed : 9852112, PubMed : 19136461, PubMed : 26257281, PubMed : 28768201). Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11 (PubMed : 9372954, PubMed : 9840937, PubMed : 19136461, PubMed : 26257281, PubMed : 28768201). Initiates transcription by RNA polymerase II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive C-terminal domain (CTD) when POLR2A is in complex with DNA, promoting dissociation from DNA and initiation (PubMed : 19136461, PubMed : 26257281, PubMed : 28768201). CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the CTD of POLR2A, allowing its escape from the promoter and elongation of the transcripts (PubMed : 9852112). Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.
Sequence similarities
Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.
Post-translational modifications
Phosphorylation of Ser-164 during mitosis inactivates the enzyme. Phosphorylation of Thr-170 is required for activity. Phosphorylated at Ser-164 and Thr-170 by CDK2.
Subcellular localisation
Nucleus
Target data
Additional targets
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Bioorganic & medicinal chemistry 26:3491-3501 PubMed29853338
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 293:10009-10025 PubMed29743242
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com